Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Investigating and resolving drug resistance in lymphoma

One of the core challenges to treating lymphoma is the common occurrence of drug resistance in this form of blood cancer. Researchers have sought to understand the mechanisms that cause lymphoma tumours to develop resistance to therapies, so they can begin to develop new effective therapies that can counteract resistance, ultimately extending lives and improving patients’ quality of life.


Go Top